The abstract is read at the publisher; the summary is JClub's.
TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike by lowering monoclonal and immune serum binding and ADCC induction in S-expressing and infected cells.
- Why it matters: Humoral immunity against spike may be shaped by viral entry cofactors, but TMPRSS2’s impact on antibody binding and effector functions has been unclear.
- What they did: In S-expressing and infected cells, TMPRSS2 decreased binding of immune serum and monoclonal antibodies and reduced ADCC induction; among 39 mAbs, S2-binding antibodies were most affected.
- The result: TMPRSS2 promoted partial S1 shedding and altered S2 conformation, reducing ACE2 binding while increasing cell-cell fusion, and this antibody-recognition effect was conserved across coronaviruses and other TMPRSS proteins.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.